Surgical resection of liver metastases from breast cancer

Surgical Oncology

Volumn 19, Issue 4, 2010, Pages

  Lermite, Emilie ^a   Marzano, Ettore ^b   Chéreau, Elisabeth ^c   Rouzier, Roman ^c   Pessaux, Patrick ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c HÔPITAL TENON   (France)

Author keywords

Breast cancer; Hepatic surgery; Liver metastasis; Prognosis; Survival

Indexed keywords

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; HUMAN; LIVER METASTASIS; LIVER SURGERY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

BREAST NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77957789330     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2009.06.005     Document Type: Review

References (46)

1. A.L. Hoe, G.T. Royle, and I. Taylor Breast liver metastases - incidence, diagnosis and outcome J R Soc Med 84 1991 714 716
2. X. Pivot, L. Asmar, and G.N. Hortobagyi A retrospective study of first indicators of breast cancer recurrence Oncology 58 2000 185 190
3. S. Carrick, S. Parker, N. Wilcken, D. Ghersi, M. Marzo, and J. Simes Single agent versus combination chemotherapy for metastatic breast cancer Cochrane Database Sys Rev 2 2005 CD003372
4. D. Ghersi, N. Wilcken, J. Simes, and E. Donoghue Taxane containing regimens for metastatic breast cancer Cochrane Database Sys Rev 2 2005 CD003366
5. S. Lord, D. Ghersi, M. Gattellari, S. Wortley, N. Wilcken, and J. Simes Antitumour antibiotic containing regimens for metastatic breast cancer Cochrane Database Sys Rev 4 2004 CD003367
6. S. Carrick, D. Ghersi, N. Wilcken, and J. Simes Platinum containing regimens for metastatic breast cancer Cochrane Database Sys Rev 2 2004 CD003374
7. D. Jones, D. Ghersi, and N. Wilcken addition of drugs to a chemotherapy regimen for metastatic breast cancer Cochrane Database Sys Rev 3 2006 CD003368
8. C. Farquhar, J. Marjoribanks, R. Basser, S. Hetrick, and A. Lethaby High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women metastatic breast cancer Cochrane Database Sys Rev 3 2005 CD003142
9. N. Wilcken, and R. Dear Chemotherapy in metastatic breast cancer: a summary of all randomised trials reported 2000-2007 Eur J Cancer 44 2008 2218 2225
10. M. Tampellini, A. Berruti, A. Gerbino, T. Buniva, M. Torta, and G. Gorzegna Relationship between CA15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease Br J Cancer 75 1997 698 702
11. M.M. Sherry, F.A. Greco, D.H. Johnson, and J.D. Hainsworth Metastatic breast cancer confined to the skeletal system Am J Med 81 1986 381 386
12. K.A. Johnson, B.S. Kramer, and J.M. Crane Management of pleural metastases in breast cancer K.I. Bland, E.M. Copeland, The breast. Comprehensive management of benign and malignant disease 1998 WB Saunders Company Philadelphia pp. 1382-8
13. D.A. Decker, D.L. Ahmann, H.F. Bisel, J.H. Edmonson, R.G. Hahn, and J.R. O'Fallon Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysis JAMA 242 1979 2075 2079
14. H. Nakano, E. Oussoultzoglou, E. Rosso, S. Casnedi, M.P. Chenard-Neu, and P. Dufour Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg 247 2008 118 124
15. D. Jaeck, and P. Pessaux Bilobar colorectal liver metastases: treatment options Surg Oncol Clin N Am 17 2008 553 568
16. J. Belghiti, K. Hiramatsu, S. Benoist, P.P. Massault, A. Sauvanet, and O. Farges Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection J Am Coll Surg 191 2000 38 46
17. E. Paulet, C. Aubé, P. Pessaux, J. Lebigot, E. Lhermite, and F. Oberti Factors limiting complete tumor ablation by radiofrequency ablation Cardiovasc Intervent Radiol 31 2008 107 115
18. R. Raab, K.T. Nussbaum, M. Behrend, and A. Weimann Liver metastases of breast cancer-results of liver resection Anticancer Res 18 3C 1998 2231 2233
19. J.C. Seifert, T.F. Weigel, U. Gonner, T.C. Bottger, and T. Junginger Liver resection for breast cancer metastases Hepatogastroenterology 46 1999 2935 2940
20. M. Selzner, M.A. Morse, J.J. Vredenburgh, W.C. Meyers, and P.A. Clavien Liver metastases from breast cancer: long-term survival after curative resection Surgery 127 2000 383 389
21. M. Yoshimoto, T. Tada, M. Saito, K. Takahashi, M. Makita, and Y. Uchida Surgical treatment of hepatic metastases from breast cancer Breast Cancer Res Treat 59 2000 177 184
22. M. Pocard, P. Pouillard, B. Asselain, M.C. Falcou, and R.J. Salmon Résections hépatiques pour métastases de cancer du sein: résultats et facteurs pronostiques (65 cas) Ann Chir 126 2001 413 420
23. D. Elias, F. Maisonnette, M. Druet-Cabanac, J.F. Ouellet, J.M. Guinebretiere, and M. Spielmann An attempt to clarify indications for hepatectomy for liver metastases from breast cancer Am J Surg 185 2003 158 164
24. M. Carlini, M.T. Lonardo, F. Carboni, M. Petric, C. Vitucci, and R. Santoro Liver metastases from breast cancer. Results of surgical resection Hepatogastroenterology 49 2002 1597 1601
25. G. Vlastos, D.L. Smith, E. Singletary, N.Q. Mirza, T.M. Tuttle, and R.J. Popat Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases Ann Surg Oncol 11 2004 869 874
26. Y. Sakamoto, J. Yamamoto, M. Yoshimoto, F. Kasumi, T. Kosuge, and N. Kokudo Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients World J Surg 29 2005 524 527
27. M. d'Annibale, P. Piovanello, V. Cerasoli, and N. Campioni Liver metastases from breast cancer: the role of surgical treatment Hepatogastroenterology 52 2005 1858 1862
28. R. Adam, T. Aloia, J. Krissat, M.P. Bralet, B. Paule, and S. Giacchetti Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244 2006 897 908
29. R. Adam, L. Chiche, T. Aloia, D. Elias, R. Salmon, and M. Rivoire Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1452 patients and development of a prognostic model Ann Surg 244 2006 524 535
30. M. Caralt, I. Bilbao, J. Cortés, A. Escartin, J.L. Lazaro, and C. Dopazo Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer Ann Surg Oncol 15 2008 2804 2810
31. P. Pessaux, E. Lermite, O. Brehant, J.J. Tuech, G. Lorimier, and J.P. Arnaud Repeat hepatectomy for recurrent colorectal liver metastases J Surg Oncol 93 2006 1 7
32. S. Schneebaum, M.J. Walker, D. Young, W.B. Farrar, and J.P. Milton The regional treatment of liver metastases from the breast cancer J Surg Oncol 55 1994 26 32
33. J.S. Stehlin Jr., P.D. de Ipolyi, P.J. Greeff, C.J. McGaff Jr., B.R. Davis, and L. McNary Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients Ann Surg 208 1 1988 23 35
34. M. Pocard, P. Pouillard, B. Asselain, and R.J. Salmon Hepatic resection in metastatic breast cancer: results and prognostic factors Eur J Surg Oncol 26 2000 155 159
35. S.R. Martinez, S.E. Young, A.E. Giuliono, and A.J. Bilchik The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases Am J Surg 191 2006 281 283
36. L. Wyld, E. Gutteridge, S.E. Pinder, J.J. James, S.Y. Chan, and K.L. Cheung Prognostic factors for patients with hepatic metastases from breast cancer Br J Cancer 89 2003 284 290
37. J.C. Sheu, J.L. Sung, and D.S. Chen Ultrasonography of small hepatic tumors using high-resolution linear-array real time instruments Radiology 150 3 1984 797 802
38. C. Aube, and J. Lebigot Contrast ultrasonography: value in diagnosis and characterisation of hepatic tumors Gastroenterol Clin Biol 27 5 Suppl 2003 B63 B70
39. P. Della Vigna, F. Cernigliaro, L. Monfardini, S. Gandini, and M. Bellomi Contrast-enhanced ultrasonography in the follow-up of patients with hepatic metastases from breast carcinoma Radiol Med 112 2007 47 55
40. L.H. Schwartz, E.J. Gandras, S.M. Colangelo, M.C. Ercolani, and D.M. Panicek Prevalence and importance of small hepatic lesions found at CT in patients with cancer Radiology 210 1999 71 74
41. H.I. Khalil, S.A. Patterson, and D.M. Panicek Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer Radiology 235 2005 872 878
42. G.C. Mueller, H.K. Hussein, R.C. Carlos, H.V. Nghiem, and I.R. Francis Effectiveness of MR imaging in characterizing small hepatic lesions: routine versus expert interpretation AJR 180 2003 673 680
43. S.A. Patterson, H.I. Khalil, and D.M. Panicek MRI evaluation of small hepatic lesions in women with breast cancer AJR 187 2006 307 312
44. S. Bipat, M.S. van Leeuwen, E.F.I. Comans, M.E. Pijl, P.M. Bossuyt, and A.H. Zwinderman Colorectal liver metastases: CT, MR imaging, and PET for diagnosis: meta-analysis Radiology 237 2005 123 131
45. E.D. Rappeport, and A. Loft Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography Abdom Imaging 32 2007 624 634
46. E.L. Rosen, W.B. Eubank, and D.A. Mankoff Fdg PET, PET/CT and breast cancer imaging Radiographics 27 2007 S215 S229